IP Library Granted Patent US 9,868,936
Granted Patent B2
US 9,868,936 · App. 14/443,652 · Granted Jan 16, 2018

Cell culture method

Inventor: Marian June Sturm (Samson, AU)
Assignee: ISOPOGEN PTY LTD
C12N5/0652A61K35/28A61K35/30A61K35/33A61K35/34A61K35/36A61K35/407C12N5/0663C12N2500/84
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,868,936
App. No.
14/443,652
Granted
Jan 16, 2018
Kind
B2
Abstract

The present invention is directed towards methods for producing cell and tissue compositions suitable for therapeutic applications to a mammal in need of a therapeutic cell or tissue treatment. In particular, the invention is directed towards a method of culturing cells for use in therapy, which method comprises (i) culturing a sample of cells in a first cell culture medium and (ii) prior to harvesting cells for use in therapy culturing the cells in a second cell culture medium.

Claims (11)

1. A method of culturing human mesenchymal stromal cells for use in allogeneic therapy comprising the steps of:

(i) providing a sample of said cells from a donor to a first culture medium;

(ii) culturing said cells in the first cell culture medium comprising fetal calf serum, for at least 18 hours until said cells are at least 70% confluent;

(iii) replacing said first cell culture medium with a second cell culture medium comprising about 2% v/v human serum albumin;

(iv) further culturing the cells for between 24 hours and 36 hours in the second cell culture medium; and

(v) harvesting said cells for use in said allogeneic therapy.

2. The method of claim 1 , wherein the mesenchymal stromal cell is a mesenchymal progenitor cell (MPC).

3. The method of claim 1 , wherein the sample of cells in step (i) comprises between 1.0×10 3 cells per cm 2 of culture vessel and 1.0×10 10 cells per cm 2 of culture vessel.

4. The method of claim 1 , wherein the sample of cells in step (i) comprises between 1.0×10 3 cells per cm 2 of culture vessel and 1.0×10 7 cells per cm 2 of culture vessel.

5. The method of claim 1 , wherein the sample of cells in step (i) are cultured until said cells are approximately 85% confluent.

6. The method of claim 1 , wherein the second cell culture medium is phenol red-free.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2015
From: STURM, MARIAN JUNE
To: ISOPOGEN PTY LTD
Reel/Frame 035758/0527 →
Priority Claims (1)
AU 2013904257 · Nov 4, 2013 · national
Continuity (1)
Related Publication 20150307844A1 · Oct 29, 2015